Logo do repositório

Primary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a review

dc.contributor.authorLu, Feifei
dc.contributor.authorJia, Siqi
dc.contributor.authorLu, Huiyuan
dc.contributor.authorZhao, Haonan
dc.contributor.authorLi, Zhe
dc.contributor.authorZhuge, Yuzheng
dc.contributor.authorRomeiro, Fernando Gomes [UNESP]
dc.contributor.authorMendez-Sanchez, Nahum
dc.contributor.authorQi, Xingshun
dc.contributor.institutionNortheastern University
dc.contributor.institutionGeneral Hospital of Northern Theater Command
dc.contributor.institutionShenyang Pharmaceutical University
dc.contributor.institutionNanjing University School of Medicine
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionNational Autonomous University of Mexico
dc.date.accessioned2025-04-29T18:43:16Z
dc.date.issued2024-01-01
dc.description.abstractBudd-Chiari syndrome (BCS) and sinusoidal obstruction syndrome (SOS) are two major vascular disorders of the liver, of which both can cause portal hypertension related complications, but their locations of obstruction are different. BCS refers to the obstruction from the hepatic vein to the junction between the inferior vena cava and right atrium, which is the major etiology of post-sinusoidal portal hypertension; by comparison, SOS is characterized as the obstruction at the level of hepatic sinusoids and terminal venulae, which is a cause of sinusoidal portal hypertension. Both of them can cause hepatic congestion with life-threatening complications, especially acute liver failure and chronic portal hypertension, and share some similar features in terms of imaging and clinical presentations, but they have heterogeneous risk factors, management strategy, and prognosis. Herein, this paper reviews the current evidence and then summarizes the difference between primary BCS and SOS in terms of risk factors, clinical features, diagnosis, and treatment.en
dc.description.affiliationCollege of Medicine and Biological Information Engineering Northeastern University
dc.description.affiliationLiver Cirrhosis Study Group Department of Gastroenterology General Hospital of Northern Theater Command
dc.description.affiliationDepartment of Life Sciences and Biopharmaceutis Shenyang Pharmaceutical University
dc.description.affiliationDepartment of Gastroenterology Drum Tower Hospital Nanjing University School of Medicine
dc.description.affiliationInternal Medicine Department Botucatu Medical School
dc.description.affiliationLiver Research Unit Medica Sur Clinic and Foundation National Autonomous University of Mexico
dc.description.affiliationUnespInternal Medicine Department Botucatu Medical School
dc.format.extent303-313
dc.identifierhttp://dx.doi.org/10.1080/03007995.2023.2288909
dc.identifier.citationCurrent Medical Research and Opinion, v. 40, n. 2, p. 303-313, 2024.
dc.identifier.doi10.1080/03007995.2023.2288909
dc.identifier.issn1473-4877
dc.identifier.issn0300-7995
dc.identifier.scopus2-s2.0-85179652838
dc.identifier.urihttps://hdl.handle.net/11449/299721
dc.language.isoeng
dc.relation.ispartofCurrent Medical Research and Opinion
dc.sourceScopus
dc.subjectBudd-Chiari syndrome
dc.subjecthepatic vein
dc.subjectinferior vena cava
dc.subjectobstruction
dc.subjectoutcome
dc.subjectrisk factor
dc.subjectsinusoidal obstruction syndrome
dc.subjecttreatment
dc.titlePrimary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a reviewen
dc.typeResenhapt
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos